Ignite Creation Date:
2025-12-24 @ 7:36 PM
Ignite Modification Date:
2025-12-25 @ 5:17 PM
Study NCT ID:
NCT05555303
Status:
RECRUITING
Last Update Posted:
2023-03-29
First Post:
2022-09-16
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Preventing Acquired Resistance: Strengthen TB Treatment by Adding Amikacin in the First Treatment Week of Multidrug-resistant Tuberculosis
Sponsor:
Rwanda Biomedical Centre
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-03-01
Start Date Type:
ACTUAL
Primary Completion Date:
2024-03
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-02
Completion Date Type:
ESTIMATED
First Submit Date:
2022-09-16
First Submit QC Date:
None
Study First Post Date:
2022-09-26
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-03-24
Last Update Post Date:
2023-03-29
Last Update Post Date Type:
ACTUAL